Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (891-900 of 1,203) with videos related to

Pageof 121
Sort By:
Cancer Immunology Research|September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-TDouglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapyCharles J Ryan, Matthew R Smith, Lawrence Fong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 16, 2020
Lagged Relationships Among Chemotherapy-Induced Peripheral Neuropathy, Sleep Quality, and Physical Activity During and After ChemotherapyHailey W Bulls, Aasha I Hoogland, Brent J Small, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 20, 2016
Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 DataHeather S L Jim, Steven K Sutton, Brent J Small, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663Mary-Ellen Taplin, Barur Rajeshkumar, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trialNicola M Neary, Caroline J Small, Alison M Wren, et al.
International Journal of Obesity (2005)|June 3, 2009
Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balanceN M Semjonous, K L Smith, J R C Parkinson, et al.
Endocrinology|August 23, 2003
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormoneCaroline R Abbott, Adam R Kennedy, Alison M Wren, et al.
Pageof 121

Showing results (891-900 of 1,203) with videos related to

Sort By:
Pageof 121
Cancer Immunology Research|September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-TDouglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapyCharles J Ryan, Matthew R Smith, Lawrence Fong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|November 16, 2020
Lagged Relationships Among Chemotherapy-Induced Peripheral Neuropathy, Sleep Quality, and Physical Activity During and After ChemotherapyHailey W Bulls, Aasha I Hoogland, Brent J Small, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 20, 2016
Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 DataHeather S L Jim, Steven K Sutton, Brent J Small, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663Mary-Ellen Taplin, Barur Rajeshkumar, Susan Halabi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trialNicola M Neary, Caroline J Small, Alison M Wren, et al.
International Journal of Obesity (2005)|June 3, 2009
Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balanceN M Semjonous, K L Smith, J R C Parkinson, et al.
Endocrinology|August 23, 2003
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormoneCaroline R Abbott, Adam R Kennedy, Alison M Wren, et al.
Pageof 121